Table 3.
COVID-19 Symptomatology.
| Controlno. (%) | Foralumab/Dexano. (%) | Foralumabno. (%) | p-value* | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Day -2 | Day 13 | Day -2 | Day 13 | Day -2 | Day 13 | Day-2 | Day 13 | ||
| **Domain 1 | 11 (68.8) | 1 (6.2) | 10 (90.9) | 0 (0) | 10 (83.3) | 1 (8.3) | 0.35 | 0.64 | |
| Domain 2 | 9 (56.2) | 0 (0) | 6 (54.5) | 0 (0) | 7 (58.3) | 0 (0) | 0.98 | 0.58 | |
| Domain 3 | 5 (31.2) | 3 (18.8) | 1 (9.1) | 0 (0) | 0 (0) | 0 (0) | 0.06 | 0.10 | |
| Domain 4 | 13 (81.2) | 2 (12.5) | 9 (81.8) | 2 (18.2) | 10 (83.3) | 0 (0) | 0.99 | 0.33 | |
| Domain 5 | 12 (75.0) | 3 (18.8) | 10 (90.9) | 3 (27.3) | 8 (66.7) | 1 (8.3) | 0.38 | 0.49 | |
| Domain 6 | 7 (43.8) | 0 (0) | 5 (45.5) | 0 (0) | 6 (50.0) | 0 (0) | 0.95 | 0.58 | |
| Domain 7 | 7 (43.8) | 2 (12.5) | 8 (72.7) | 1 (9.1) | 5 (41.7) | 0 (0) | 0.24 | 0.46 | |
| Domain 8 | 13 (81.2) | 2 (12.5) | 8 (72.7) | 2 (18.2) | 7 (58.3) | 2 (16.7) | 0.41 | 0.91 | |
|
†Domains/pt. # (mean ± SD) |
4.8 ( ± 1.5) | 0.8 ( ± 1.0) | 5.2 ( ± 0.6) | 0.7 ( ± 0.9) | 4.4 ( ± 1.3) | 0.3 ( ± 0.7) | 0.23 | 0.37 | |
**For each Domain, the number (%) of patients experiencing symptoms in that Domain at day -2 and day 13 are shown. *p-value for each domain is from a chi-squared test comparing the proportions across the three groups at each time point. For the domains per patient, the three groups were compared using a Kruskal-Wallis test. # Plus–minus values are means ± SD. †Domains/pt = the average number of Domains in which patients experienced symptoms. Pt, patient; Dexa, Dexamethasone.